Literature DB >> 3159548

Graft-vs.-host reactions: mechanisms and contemporary theories.

H Bril, R Benner.   

Abstract

A graft-vs.-host (GvH) reaction can be initiated by injection of immunocompetent lymphocytes into a histoincompatible host that is unable to reject these cells. The reaction is characterized by splenomegaly, hepatomegaly, lymph node atrophy, body weight loss, dermatitis, and diarrhea, often leading to mortality. The onset and severity of the GvH reaction are determined by differences in histocompatibility antigens between the donor and the acceptor, and by the number and nature of the transplanted allogeneic cells. Many different in vivo and in vitro systems have been devised for experimental studies of the GvH reaction. In several of these models, however, different parameters are measured. Furthermore, the conclusions drawn from these investigations sometimes contradict each other. This paper reviews the experimental data, and discusses the mechanisms underlying the GvH reaction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159548     DOI: 10.1080/10408368509176815

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  4 in total

Review 1.  Graft versus leukemia in bone marrow transplantation.

Authors:  M Boranić
Journal:  Blut       Date:  1988-08

2.  Sulfur mustard induces immune sensitization in hairless guinea pigs.

Authors:  Neerad C Mishra; Jules Rir-sima-ah; Thomas March; Waylon Weber; Janet Benson; Richard Jaramillo; Jean-Clare Seagrave; Gregory Schultz; Gary Grotendorst; Mohan Sopori
Journal:  Int Immunopharmacol       Date:  2009-11-01       Impact factor: 4.932

3.  The role of interferon alpha/beta in the induction of intestinal pathology in mice.

Authors:  P Garside; M V Felstein; E A Green; A M Mowat
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

4.  Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody.

Authors:  A L Hoffman; L Makowka; D V Cramer; X Cai; A Pascualone; B F Banner; D G Sheahan; P Rettinger; T E Starzl
Journal:  J Invest Surg       Date:  1989       Impact factor: 2.533

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.